In one of our recent posts, we discussed a survey coming from New Mexico, which found 80% of the 37 respondents enrolled in a medical marijuana program reduced their opioid use, and 40% stopped opioid use to use cannabis. Now, the preliminary results from another study conducted by private research firm Aclara in Illinois supports these results. In the study involving 400 Illinois patients, 67% stopped using opioids after enrolling in the state’s medical marijuana program. Additionally, 37% stopped using all conventional medications, and 60% reduced their use of prescription drugs and reduced their trips to the pharmacy. The study also reached out to 500 pharmacists in Illinois, and found 87% thought medical cannabis should be legal, and 69% thought pharmacies should have the ability to dispense the product. Carmen Brace, founder of Aclara Research, explains, “Patients are using cannabis, successfully, to wean themselves off opioid usage.” She continues to link the results of this study to one published in the Journal of Pain in 2016, in which chronic pain patients successfully reduced opioid use by 64%.
These studies are especially important in light of the opioid crisis, in which opioid-related deaths have skyrocketed. In one analysis from Johns Hopkins Bloomberg School of Public Health in 2016, states that had implemented medical marijuana programs saw 25% fewer opioid-related deaths than states that did not have such programs. All of these studies point to the suggestion that cannabis can, in fact, fight the opioid crisis. This information has been provided by Merry Jane and approved by our Chief Medical Officer.